Manufacturer
122 recalls in our database name Glenmark Pharmaceuticals Inc., USA as the manufacturing or recalling firm.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Glenmark Pharmaceuticals is voluntarily recalling Diltiazem Hydrochloride 120mg Extended-Release Capsules nationwide due to manufacturing process deviations. Consumers should verify lot numbers and consult their pharmacist.
Glenmark Pharmaceuticals is recalling Teriflunomide tablets (14mg) due to manufacturing quality control violations. The recall affects products distributed nationwide.
Glenmark Pharmaceuticals is voluntarily recalling Indomethacin Extended-Release Capsules (75mg) distributed nationwide due to Good Manufacturing Practice deviations identified during FDA oversight.
Glenmark Pharmaceuticals is recalling solifenacin succinate 10mg tablets nationwide due to manufacturing process deviations. The voluntary recall affects specific lot numbers distributed across the United States.
Glenmark Pharmaceuticals is recalling Saxagliptin 2.5mg tablets nationwide due to manufacturing quality issues. The firm initiated this voluntary recall on March 13, 2025.
Glenmark Pharmaceuticals is voluntarily recalling Lacosamide Tablets 200mg due to manufacturing quality deviations. The prescription antiseizure medication is distributed nationwide.
Glenmark Pharmaceuticals is recalling specific lots of Nitroglycerin sublingual tablets 0.4 MG nationwide due to manufacturing process deviations.
Glenmark Pharmaceuticals is voluntarily recalling Prochlorperazine Maleate 10mg tablets (NDC# 68462-890-01) distributed nationwide due to manufacturing process deviations. No illnesses or injuries have been reported.
Glenmark Pharmaceuticals is recalling Ranolazine Extended-Release 1000mg tablets (Lot 17240040) nationwide due to manufacturing deviations. This is a voluntary, firm-initiated recall.
Glenmark Pharmaceuticals is recalling nitroglycerin sublingual tablets nationwide due to manufacturing practice deviations. Affected lots expire in November and December 2025; no illnesses have been reported.
Glenmark Pharmaceuticals is recalling Naproxen Sodium 550mg tablets nationwide due to manufacturing process deviations. The recall is voluntary and firm-initiated.
Glenmark Pharmaceuticals recalls Propafenone Hydrochloride Extended-Release Capsules (325mg) nationwide due to manufacturing quality violations. Affected lot #17230767 expires March 2025.
Glenmark Pharmaceuticals is recalling Lacosamide 100mg tablets nationwide due to manufacturing practice deviations. This is a voluntary recall initiated by the manufacturer.
Glenmark Pharmaceuticals is recalling Rufinamide 200mg tablets nationwide due to manufacturing process deviations. The voluntary recall affects certain lot numbers with July 2025 expiration dates.
Glenmark Pharmaceuticals is recalling Pravastatin Sodium 20mg tablets nationwide due to manufacturing quality deviations. The voluntary recall was initiated on March 13, 2025.
Glenmark Pharmaceuticals is voluntarily recalling Carvedilol 12.5 mg tablets nationwide due to manufacturing deviations found in the production process.
Glenmark Pharmaceuticals is recalling Voriconazole 50mg tablets nationwide due to manufacturing process deviations. The prescription antifungal drug was voluntarily recalled after detecting current good manufacturing practice violations.
Glenmark Pharmaceuticals is voluntarily recalling Cetirizine HCL 10mg tablets distributed nationwide. The recall was initiated due to Current Good Manufacturing Practice deviations.
Glenmark Pharmaceuticals Inc. USA is recalling Clindamycin Hydrochloride Capsules, USP 300mg due to CGMP deviations. The product has been distributed nationwide.
Glenmark Pharmaceuticals is recalling certain Pravastatin Sodium tablets nationwide due to manufacturing process deviations. Affected lots with expiration dates between March and November 2026 were distributed throughout the United States.
Glenmark Pharmaceuticals is voluntarily recalling Voriconazole tablets nationwide due to manufacturing process deviations. No illnesses or injuries have been reported.
Glenmark Pharmaceuticals is recalling Propafenone Hydrochloride Extended-Release Capsules 325mg nationwide due to Current Good Manufacturing Practice deviations. No illness or injury has been reported.
Glenmark Pharmaceuticals is voluntarily recalling specific lots of Colesevelam Hydrochloride Tablets due to manufacturing process deviations. The FDA classified this as a Class II recall affecting nationwide distribution.
Glenmark Pharmaceuticals is voluntarily recalling Saxagliptin 5mg tablets nationwide due to CGMP deviations. Affected lot numbers are 17232460 and 17241194.
Glenmark Pharmaceuticals is recalling Solifenacin Succinate 5mg tablets nationwide due to manufacturing quality deviations. The affected bottles are distributed across the United States.